Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dose-dense adjuvant chemotherapy for primary breast cancer
    Journal Article

    Fornier, M.; Norton, L.
    Breast Cancer Research (2005)

    Fulltext@MSK | Save
  • Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies
    Journal Article

    Esteva, F. J.; Cheli, C. D.; Fritsche, H.; Fornier, M.; Slamon, D.; Thiel, R. P.; Luftner, D.; Ghani, F.
    Breast Cancer Research (2005)

    Fulltext@MSK | Save
  • Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients
    Journal Article

    Dressler, L. G.; Berry, D. A.; Broadwater, G.; Cowan, D.; Cox, K.; Griffin, S.; Miller, A.; Tse, J.; Novotny, D.; Persons, D. L.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
    Journal Article

    Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
    Lancet (2005)

    Fulltext@MSK | Save
  • A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American joint committee on cancer staging system
    Journal Article

    Wong, S. L.; Kattan, M. W.; McMasters, K. M.; Coit, D. G.
    Annals of Surgical Oncology (2005)

    Fulltext@MSK | Save
  • The role of sentinel lymph node biopsy in the management of thin melanoma
    Journal Article

    Wong, S. L.
    American Journal of Surgery (2005)

    Fulltext@MSK | Save
  • A comparison of bilateral breast cancers in BRCA carriers
    Journal Article

    Weitzel, J. N.; Robson, M.; Pasini, B.; Manoukian, S.; Stoppa-Lyonnet, D.; Lynch, H. T.; McLennan, J.; Foulkes, W. D.; Wagner, T.; Tung, N.; more...
    Cancer Epidemiology Biomarkers and Prevention (2005)

    Fulltext@MSK | Save
  • Problems in colon cancer and a child with renal lymphoma: Case 1. Metastatic colon cancer to the ovaries in a krukenberg-like pattern
    Journal Article

    Traina, T. A.; Leonard, G. D.; Tang, L.; Paty, P. B.; Maki, R. G.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary
    Journal Article

    Tornos, C.; Soslow, R.; Chen, S.; Akram, M.; Hummer, A. J.; Abu Rustum, N.; Norton, L.; Tan, L. K.
    American Journal of Surgical Pathology (2005)

    Fulltext@MSK | Save
  • Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sensitizing tumors to paclitaxel
    Journal Article

    Solit, D. B.; She, Y.; Lobo, J.; Kris, M. G.; Scher, H. I.; Rosen, N.; Sirotnak, F. M.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save